No Data
No Data
10-K: FY2024 Annual Report
Windtree Therapeutics Reports FY24 EPS ($104.35) Vs. ($4,718.84) Last Year
Windtree Therapeutics FY24 Loss $1.8M >WINT
Press Release: Windtree Therapeutics Reports Year-End 2024 Financial Results and Provides Key Business Updates
$WINT Earnings Preview: Recent $WINT Insider Trading, Hedge Fund Activity, and More
Windtree Therapeutics Delays Annual Report Filing
ReoNnA : what do you think about $Wang & Lee Group (WLGS.US)$
Jaguar8 OP ReoNnA : not right now. i will have to evaluate stocks later
Mark Blihar : I'm new to this appreciate u for ur info...
mikem85 : nice to see you sir
小錢和正 : All AI pharmaceutical stocks in the rxrx daily and weekly form is a super big bull stock, the daily line in the replication of the weekly form, if the daily and weekly resonance that, RXRX will erupt into an amazing attack state!
View more comments...